Technology Offerings

New Markers Enhance Rheumatoid Arthritis Diagnosis

The combined use of RFs with the anti-cyclic citrullinated peptide (anti-CCP) or assays resulted in detection levels of about 40% of early arthritis patients and 70-80% of established RA patients.

Further Information: PDF

ipal GmbH
Phone: +49 (0)30/2125-4820

Contact
Ursula Haufe

Comments (0)

Write a comment